AmDerma Pharmaceuticals and Oculus Innovative Sciences have signed a multi-country agreement to develop and commercialize Microcyn technology drug compounds for major dermatological conditions. The agreement includes licensing of the ...
Tags: Microcyn technology drug compounds, dermatology compounds